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Dear Editor,
Immune thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by a 
low platelet count caused by destruction of antibody-sensitized platelets in the 
reticuloendothelial system, such as the spleen [1]. Overall, the key element is the loss of 
self-tolerance, leading to the production of autoantibodies directed against platelet 
antigens. In children with ITP, the clinically important subgroup is those who have 
platelet counts less than or equal to 20x109 /L and require ongoing platelet-enhancing 
therapy because of bleeding symptoms. In these patients, second-line therapies are 
indicated. Laparoscopic splenectomy has now been accepted as an effective treatment 
with minimal risk of serious complications in expert hands. 
Rarely, ITP can be complicated by intracranial haemorrhage and this usually occurs in the 
setting of extremely low platelet counts of <10 x 109 /L [2]. Although rare, it is associated 
with mortality rates of approximately 50%, while among the survivors, neurological 
deficits are common. Emergent splenectomy can result in immediate improvement in 
platelet counts in approximately 80% of patients [3]. Nevertheless this procedure carries 
the risk of perioperative bleeding, and especially in haemodynamically unstable patients. 
Here, we present the successful use of splenic artery embolization as a temporizing 
measure prior to laparoscopic splenectomy in a patient with chemo-resistant ITP and 
presented with intracranial haemorrhage.
A 12-year old boy with a previous history of diffuse large B–cell lymphoma in remission 
first presented with a 2-month history of increased generalised petechiae and gum 
bleeding. He was diagnosed with immune thrombocytopenic purpura after laboratory 
investigations. However, treatment with prednisolone, cyclosporine, intravenous 
immunoglobulins and rituximab all failed to increase his platelet count. Subsequently, he 
was admitted as an emergency with sudden onset of frontal headache and altered 
consciousness. Physical examination showed a reduced Glasgow Coma Score of 12/15, 
right upper limb weakness, signs of meningeal irritation and aphasia. Computed 
tomography of the brain showed a crescent rim of extra-axial collection causing mild 
inward displacement of the cerebral hemisphere over the left frontal and temporo-parietal 
region, suggesting subacute haematoma (figure 1). Platelet count at admission was 7 x 
109 / L.
In view of the serious nature of his symptoms and the very low platelet count, we decided 
to proceed with splenic artery embolisation on the day of admission with a combination 
of stainless steel coils and polyvinyl alcohol particles (figure 2). His platelet count rose 
rapidly the following day to above 100 x 109 /L. Laparoscopic splenectomy was 
performed 2 days later with no complications. No blood products were transfused intra or 
peri-operatively. Platelet count continued to rise to 226 x 109 /L two days after the 
operation. He made a full neurological recovery and was discharged 7 days after his 
operation. At last review, his platelet count was 380 x 109 /L and he was taken off all 
medication. 
In patients with acute immune thrombocytopenic purpura, splenectomy is indicated in 
those with bleeding symptoms with platelet counts of less than 20 x 109 /L [4]. 
Laparoscopic splenectomy is currently the preferred method for the surgical management 
of haematologically-related splenic disorders as it has been shown to result in faster 
recovery periods and reduced postoperative pain [5]. However, haemorrhagic 
complications remain a concern for this procedure given the spleen’s rich vascularity and 
maneuvers required for the operation [6,7]. The risk of such events occurring may be 
increased in patients with very low platelet counts. Splenic artery embolisation has 
previously been used to treat various conditions, which include chronic immune 
thrombocytopenic purpura, hereditary spherocytosis, splenic trauma in 
haemodynamically unstable patients, and also in patients with liver cirrhosis with 
hypersplenism [8-11]. It has been demonstrated to result in significantly reduced blood 
loss during subsequent laparoscopic splenectomy compared to patients who received 
laparoscopic splenectomy as a sole treatment [12]. In our patient, we carried out complete 
splenic artery embolisation in an acute setting, with splenectomy in a staged fashion, with 
both procedures yielding a considerable improvement in platelet count. The rationale for 
performing complete embolisation was because of the unlikelihood of success for partial 
embolisation in our patient, due to the refractory nature of his disease. Splenectomy after 
embolisation is required to reduce the chances of developing post infarction syndrome 
(fever, left upper quadrant pain, risk of infection and abscess formation). Other potential 
complications associated with embolisation are related to migration or inappropriate 
placement of embolic material. Although it has recently been suggested that splenic 
artery embolisation preceeding laparoscopic splenectomy should not be carried out 
routinely as appropriate use of blood products and correct surgical technique will be 
adequate in controlling blood loss [13], in this patient, an extremely low platelet count 
and intracranial bleeding necessitated immediate intervention. As emergent splenectomy 
had a significantly higher risk of haemorrhagic complications, splenic artery embolisation 
could provide a temporary bridge before splenectomy. We therefore propose that in the 
treatment of children with life threatening acute immune thrombocytopenic purpura, 
splenic artery embolisation preceeding laparoscopic splenectomy may be a viable method 
of stabilision.
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Figure legends
Figure 1 - An axial computed tomography of the brain showing intracranial haemorrhage 
in the left parietal/occipital area (arrow). 
Figure 2 -  A fluoroscopic image taken after splenic artery embolisation with coils. The 
celiac artery is highlighted with contrast.  
Fig 1
Fig
Fig 2
